yttrium Y 90 monoclonal antibody BrE-3
Term · Oncology and biomedicine · MLC-T-ONC-017634
A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein mucin chelated to the radioisotope yttrium-90. Yttrium Y 90 monoclonal antibody BrE-3 binds to tumor cells expressing epithelial glycoprotein mucin, selectively delivering a cytotoxic dose of beta radiation.
| Identifier | MLC-T-ONC-017634 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MOAB BrE-3, yttrium Y 90 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017634",
"term": "yttrium Y 90 monoclonal antibody BrE-3",
"field": "Oncology and biomedicine",
"definition": "A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein mucin chelated to the radioisotope yttrium-90. Yttrium Y 90 monoclonal antibody BrE-3 binds to tumor cells expressing epithelial glycoprotein mucin, selectively delivering a cytotoxic dose of beta radiation.",
"synonyms": [
"MOAB BrE-3, yttrium Y 90"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/yttrium-y-90-monoclonal-antibody-bre-3/"
}
Record 17,569 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.